Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Passarelli

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Biomed Research International|January 7, 2014
Biodistribution and molecular studies on orally administered nanoparticle-AON complexes encapsulated with alginate aiming at inducing dystrophin rescue in mdx miceMaria Sofia Falzarano, Chiara Passarelli, Elena Bassi, et al.
European Journal of Human Genetics : EJHG|April 21, 2026
Revisiting LSDMCA: male lethality escape and genotype-phenotype correlationsAlfonso Manuel D'Alessio, Alessia Indrieri, Giuseppina Vitiello, et al.
Frontiers in Genetics|July 15, 2022
Genetics of Inherited Retinal Diseases in Understudied Ethnic Groups in Italian HospitalsPaolo Enrico Maltese, Leonardo Colombo, Salvatore Martella, et al.
RMD Open|May 13, 2026
Clinical phenotype and laboratory markers in patients affected by haploinsufficiency of A20 (HA20): a case series from two Italian centresLaura De Nardi, Silvia Federici, Eleonora De Martino, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|September 5, 2017
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis‑acting DNA elements that govern muscle dystrophin expressionSamuele Gherardi, Matteo Bovolenta, Chiara Passarelli, et al.
Frontiers in Immunology|June 26, 2026
Unexpected genetically determined immune dysregulation with liver involvement: GIMAP5 therapeutic dilemmas between targeted therapy and HSCTMattia Moratti, Michele La Manna, Lucia Colucci, et al.
Annals of Neurology|October 31, 2012
DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsyRita Barone, Chiara Aiello, Valérie Race, et al.
Journal of Clinical Immunology|May 31, 2019
Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI SyndromeStefano Volpi, Antonella Insalaco, Roberta Caorsi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 6, 2014
Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variantsJanneke C van den Bergen, Monika Hiller, Stefan Böhringer, et al.
Nature Medicine|August 11, 2014
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and miceNicolas Wein, Adeline Vulin, Maria S Falzarano, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Biomed Research International|January 7, 2014
Biodistribution and molecular studies on orally administered nanoparticle-AON complexes encapsulated with alginate aiming at inducing dystrophin rescue in mdx miceMaria Sofia Falzarano, Chiara Passarelli, Elena Bassi, et al.
European Journal of Human Genetics : EJHG|April 21, 2026
Revisiting LSDMCA: male lethality escape and genotype-phenotype correlationsAlfonso Manuel D'Alessio, Alessia Indrieri, Giuseppina Vitiello, et al.
Frontiers in Genetics|July 15, 2022
Genetics of Inherited Retinal Diseases in Understudied Ethnic Groups in Italian HospitalsPaolo Enrico Maltese, Leonardo Colombo, Salvatore Martella, et al.
RMD Open|May 13, 2026
Clinical phenotype and laboratory markers in patients affected by haploinsufficiency of A20 (HA20): a case series from two Italian centresLaura De Nardi, Silvia Federici, Eleonora De Martino, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|September 5, 2017
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis‑acting DNA elements that govern muscle dystrophin expressionSamuele Gherardi, Matteo Bovolenta, Chiara Passarelli, et al.
Frontiers in Immunology|June 26, 2026
Unexpected genetically determined immune dysregulation with liver involvement: GIMAP5 therapeutic dilemmas between targeted therapy and HSCTMattia Moratti, Michele La Manna, Lucia Colucci, et al.
Annals of Neurology|October 31, 2012
DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsyRita Barone, Chiara Aiello, Valérie Race, et al.
Journal of Clinical Immunology|May 31, 2019
Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI SyndromeStefano Volpi, Antonella Insalaco, Roberta Caorsi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 6, 2014
Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variantsJanneke C van den Bergen, Monika Hiller, Stefan Böhringer, et al.
Nature Medicine|August 11, 2014
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and miceNicolas Wein, Adeline Vulin, Maria S Falzarano, et al.
Pageof 5